[Myalgia in Neuro-Behçet's disease. Medication side effects or expression of underlying disease].
In this report we present the 9-year course of disease in a woman of Turkish origin suffering from Behçet's disease with parenchymal CNS involvement combined with myalgia. Differential diagnoses, such as drug-induced neuromyopathy were excluded on the basis of electromyographic and bioptic tests. We were able to arrest progression of symptoms of both the myopathy and the Neuro-Behçet's disease by means of increased combined immunosuppressive therapy.
Krämer
M
M
Klinik für Neurologie mit klinischer Neurophysiologie, Alfried Krupp von Bohlen und Halbach Krankenhaus, Alfried-Krupp-Strasse 21, 45117 Essen. markus.kraemer1977@gmx.de
Baumgärtel
M W
MW
Neuen-Jacob
E
E
Berlit
P
P
D000328:Adult; D001379:Azathioprine / Q000009:adverse effects / Q000627:therapeutic use; D001528:Behcet Syndrome / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D001706:Biopsy; D001927:Brain Diseases / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D004576:Electromyography; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D018482:Muscle, Skeletal / Q000187:drug effects / Q000473:pathology; D009468:Neuromuscular Diseases / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D009902:Optic Neuritis / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D011241:Prednisone / Q000009:adverse effects / Q000627:therapeutic use; D015866:Uveitis, Posterior / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D001379:Azathioprine; D011241:Prednisone